U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840288) titled 'Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry' on Feb. 17.
Brief Summary: To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.
Study Start Date: Aug. 31, 2025
Study Type: OBSERVATIONAL
Condition:
Thoracic Tumors
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Disclaimer: Curated by HT Syndication....